India's First One Health Institute In Nagpur To Track Human, Animal & Environmental Diseases Together

The institute will test samples nationwide to trace disease spread and issue timely alerts if a new virus is found in animals, helping prevent transmission to humans
The country's first One Health Institute is under construction in Nagpur, aiming to simultaneously monitor diseases affecting humans, animals and the environment. Dr. Pragya Yadav, Director of the National Institute for One Health, highlighted that this significant initiative by the government is geared towards addressing future epidemic challenges more effectively.
The National Institute for One Health (NIOH) in Nagpur, Maharashtra, will track diseases across humans, animals, and the environment, enabling early detection.
What Makes The Institute Stand Out?
The institute will identify zoonotic diseases such as COVID, bird flu, and the Nipah virus. A collaborative effort involving doctors, veterinarians, scientists, and environmental experts will work towards understanding the origins of these diseases.
When Will It Be Ready?
According to Dr. Yadav, the institute is expected to be fully operational within the next two years, with rapid progress being made on its building and modern laboratories.
How Will It Prevent Epidemics?
The institute's role in epidemic prevention involves testing samples from across the country to trace and analyse how diseases spread. Should a new virus be detected in any animal, timely alerts will be issued to prevent the disease from spreading to humans.
Additionally, the institute will maintain connections with global agencies like the World Health Organization (WHO), the Food and Agriculture Organization (FAO), and the World Organisation for Animal Health (OIE), positioning India to participate in global epidemic warnings and solutions.
Equipped with high-safety labs such as BSL-2, BSL-3, and BSL-4, the institute will collaborate with various ministries, including health, animal husbandry, and environment, to determine whether diseases originate from animals, the environment, or other factors.
What Is One Health?
The concept of One Health revolves around understanding the interconnected health of humans, animals and the environment to prevent diseases. The National Institute for One Health will serve as a collaborative platform, fostering data monitoring across departments to ensure timely responses to future epidemics.
Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated!
First Published:
June 18, 2025, 19:17 IST

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Hans India

2 hours ago

• Hans India

Airborne fungal spores may help predict Covid, flu surge: Study

New Delhi: Monitoring fungal spores in the outdoor air can predict surges in flu and Covid-19 infections, according to a study. Researchers from Lynn University in Florida, US, discovered that airborne concentrations of fungal spores -- but not pollen -- were strongly linked to increases in flu and Covid-19 cases. When airborne concentrations of fungal spores rose, the scientists often saw a jump in infections within a few days. The study models were able to predict flu and Covid-19 surges with high accuracy, particularly in the fall season. However, pollen didn't show the same connection or prediction. 'The findings from our study suggest that monitoring airborne fungal spore levels could help predict short-term outbreaks (spikes) of flu and Covid-19, giving public health systems an early warning signal,' said Felix E. Rivera-Mariani, Associate Professor of Biochemistry at Lynn. 'Our findings also highlight the potential role of environmental factors -- not just person-to-person spread -- in contributing to the incidence of respiratory viral infections. That could open new doors for targeted public health alerts, especially in areas with high outdoor airborne fungi," Rivera-Mariani added. In the study, the team examined daily data from 2022 to 2024, in two major health regions in Puerto Rico—San Juan and Caguas. The data included the daily incidence of people diagnosed with Covid-19 and flu, and the concentrations of airborne fungal spores and pollen recorded on the same days. The scientists then implemented statistical and machine learning models to see if high levels of these environmental exposures could predict spikes in flu and Covid-19 cases within the same week or the following week (called lag-effect). 'The findings may help inform environmental risk alerts, particularly for vulnerable populations like the elderly or those with asthma and allergic rhinitis,' Rivera-Mariani said. The study was presented at ASM Microbe 2025 in Los Angeles, the annual meeting of the American Society for Microbiology.

The Hindu

3 hours ago

• The Hindu

What you need to know about the ‘razor blade' Covid variant

Covid-19, it seems, can never stay out of the news for very long. One variant of the virus has been making headlines recently for being behind a spike in cases, particularly in China and the United States, and for causing 'razor blade' throats, or a severely painful sore throat. What do you need to know about this? Read on, to find out. The 'razor blade' throat, reports indicate, is being caused by the NB.1.8.1 variant of the virus, an Omicron-descendent variant dubbed as 'Nimbus' and currently accounting for a large number of cases worldwide. On May 23, 2025, the World Health Organization classified this variant as a 'SARS-CoV-2 variant under monitoring (VUM) with increasing proportions globally, while LP.8.1 is starting to decline.' A technical document by the WHO states: 'Considering the available evidence, the additional public health risk posed by NB.1.8.1 is evaluated as low at the global level. Currently approved COVID-19 vaccines are expected to remain effective to this variant against symptomatic and severe disease. Despite a concurrent increase in cases and hospitalizations in some countries where NB.1.8.1 is widespread, current data do not indicate that this variant leads to more severe illness than other variants in circulation.' Symptoms remain similar to those caused by other Covid-19 strains and include fever, a sore throat, cough, runny nose and tiredness. Media reports indicate some patients complaining of a sharp, stabbing pain while swallowing, often at the back of the throat, akin to 'swallowing a razor blade'. However, it is unclear if this is a distinctive symptom of this variant The WHO, in its technical document, had said spike mutations in this variant could increase its transmissibility. In India, according to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), one case of NB.1.8.1 was identified in April in Tamil Nadu and four cases of LF.7 were detected in Gujarat in May. As of May, the most common variant remained JN.1, comprising 53 % of samples tested, followed by BA.2 (26 %) and other Omicron sublineages (20 %). In June, a media report stated about 163 cases of the COVID-19 variant XFG, had been detected, according to INSACOG data. Earlier this week, Naveen Kumar, Director, National Institute of Virology (NIV), Pune, said surveillance and genome sequencing have been scaled up. He said genomic analysis had revealed the surge was due to the JN.1.16 sub-lineage of the Omicron variant, and that since May 2025, it had been replaced by the XFG (LF.7 and LP.81.2) recombinant variant. Doctors in India have reiterated that Covid-19 is now co-circulating with other seasonal infections and that they do not expect any major waves of the kind seen in 2021 and 2021. Spikes and dips however, may continue. Personal protection and hygiene measures such as hand washing, avoiding crowded places when possible or masking up, and protecting vulnerable segments of the population must continue, they have said. As of Friday, June 20, 2025, India's tally of active Covid-19 cases dipped to 5,608 from the 7,000 plus mark last week, and four new deaths were reported, taking the total toll this year to 120.

India Today

4 hours ago

• India Today

Razor blade sore throat emerges as key symptom of new Covid strain

A new Covid-19 variant, NB.1.8.1, now dubbed 'Nimbus', rapidly spreading in several countries and is making headlines for a painful and distinctive symptom: a severely sore throat described by patients as feeling like "swallowing razor blades."This unusually intense throat pain is fast becoming an emerging symptom of the new strain, according to international symptom, being called the "razor blade throat", is affecting individuals across the US, a report by the Associated Press The World Health Organisation (WHO) has maintained that the variant does not currently pose a higher risk of severe illness compared to previous contracting a COVID-19 infection are reporting an unusually intense sore throat, described as feeling like swallowing razor blades, as per IS THE NIMBUS VARIANT?The NB.1.8.1 variant, now nicknamed 'Nimbus', is part of the evolving SARS-CoV-2 virus family, which health authorities say is increasingly behaving like a seasonal virus, similar to the Nimbus has garnered attention due to its unusual symptom profile and its rapid geographical spread in recent of mid-May, the WHO reported that Nimbus accounted for nearly 11% of sequenced Covid-19 samples US Centers for Disease Control and Prevention (CDC) also confirmed that the variant had been detected through airport screenings of travelers arriving from Asia in states such as California, Virginia, New York, and India, INSACOG (the Indian SARS-CoV-2 Genomics Consortium), identified four circulating variants in the country: LF.7, XFG, JN.1.16, and SYMPTOMS TO WATCH FORBeyond the intense sore throat, common symptoms of the Nimbus variant continue to mirror those of earlier strains, including fever and chills, cough, headache, and shortness of ARE INDIAN EXERTS SAYING?Cases in India have marginally decreased. As of June 20, the active Covid-19 caseload, stands at 5,608 cases, indicating a downward trend in infections despite the presence of new to the WHO, Nimbus is currently classified as low risk, with no evidence of increased severity or mortality and most patients are managing their symptoms via home isolation.